Difficulty: Medium
Average Score: 89%
Practice
The most important complication of streptokinase therapy is
Correct answer
B
Rationale
The most important complication of streptokinase therapy is bleeding. Streptokinase is a thrombolytic agent used to dissolve blood clots and restore blood flow in conditions like myocardial infarction and pulmonary embolism. One of the main side effects of thrombolytic therapy is the risk of bleeding, as the medication can break down not only the abnormal clots but also normal blood clots essential for hemostasis. This can lead to serious bleeding complications, which makes monitoring for signs of bleeding a crucial aspect of care when administering streptokinase.
Option A, hypotension, is not the most important complication of streptokinase therapy. While hypotension can occur as a side effect of the medication due to vasodilation, it is generally less concerning than bleeding in this context.
Option C, fever, is not a common or significant complication of streptokinase therapy. Fever is more likely to be associated with an underlying condition that necessitated the use of thrombolytic therapy rather than being a direct effect of streptokinase.
Option D, anaphylaxis, is a potential but less common complication of streptokinase therapy. While allergic reactions can occur, they are not as prevalent or as serious as bleeding in the context of thrombolytic treatment.
Educationally, understanding the complications of hematologic drugs like streptokinase is essential for healthcare providers involved in the management of patients with clotting disorders. Recognizing the most important adverse effects helps in early identification, prompt intervention, and improved patient outcomes. Healthcare professionals need to be vigilant in monitoring for signs of bleeding when administering thrombolytic therapy to mitigate the risks associated with this potentially life-saving treatment.
Option A, hypotension, is not the most important complication of streptokinase therapy. While hypotension can occur as a side effect of the medication due to vasodilation, it is generally less concerning than bleeding in this context.
Option C, fever, is not a common or significant complication of streptokinase therapy. Fever is more likely to be associated with an underlying condition that necessitated the use of thrombolytic therapy rather than being a direct effect of streptokinase.
Option D, anaphylaxis, is a potential but less common complication of streptokinase therapy. While allergic reactions can occur, they are not as prevalent or as serious as bleeding in the context of thrombolytic treatment.
Educationally, understanding the complications of hematologic drugs like streptokinase is essential for healthcare providers involved in the management of patients with clotting disorders. Recognizing the most important adverse effects helps in early identification, prompt intervention, and improved patient outcomes. Healthcare professionals need to be vigilant in monitoring for signs of bleeding when administering thrombolytic therapy to mitigate the risks associated with this potentially life-saving treatment.